Location: Home
  • search
  • go
  • Relate News
  • 1/18/2023China Issues Notice to Encourage Foreign Capital to Set up R&D Centers...
  • 1/18/2023NHSA and MOHRSS Jointly Issues the 2022 National Drug Reimbursement Li...
  • 1/18/2023Moderna in Active Discussions with China to Supply COVID Vaccines
  • 1/17/2023Sinovent Pharma Sign Two Out-licensing Deals with METiS and AmMax Bio
  • 1/16/2023NHSA Holds 2023 National Healthcare Security Conference, Laying Out Po...
  • 1/16/2023The China Imperative for Multinational Companies
  • 1/13/2023HSMAP: Chinese MedPharm Industry Operations Report 2022
  • 1/13/2023PhIRDA: Early Stage Financing and Recent Startups Dominate Chinese Pha...
  • 1/13/2023AstraZeneca, Genertec Meheco Sign Deal for COVID Therapy Evusheld in C...
  • 1/13/2023MNCs to Play Key Role in Improving Cardiovascular Disease Management A...
  • 1/12/2023Information Collection on the 8th VBP Officially Initiated
  • 1/12/2023Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...
  • 1/12/2023MNC Incubators in China (PharmaDJ)
  • 1/11/2023Merck to Take Legal Action against Unauthorized Distributors of Its C...
  • 1/11/2023Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...
  • 1/11/2023Hepalink Invests $60M with TPG Biotechnology fund
  • 1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...
  • 1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...
  • 1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...
  • 1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
  • 1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)
  • 1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)
  • 1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...
  • 1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
  • 1/6/2023China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
  • 1/6/2023Recent Executive Moves
  • 1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
  • 1/5/2023CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
  • 1/5/2023NMPA Holds National Drug Regulatory Conference in Beijing
  • 1/5/20232022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
  • Page:54/356 Total number of articles:10665: [First][<<] [52] [53] [54] [55] [56] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group